Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» ICER declares costs of approved CAR-T therapies aligned with clinical benefit
ICER declares costs of approved CAR-T therapies aligned with clinical benefit
ICER declares costs of approved CAR-T therapies aligned with clinical benefit
Submitted by
admin
on February 20, 2018 - 9:58am
Source:
BioWorld
News Tags:
CAR-T
ICER
Gilead Sciences
Yescarta
Novartis
Kymriah
drug pricing
Headline:
ICER declares costs of approved CAR-T therapies aligned with clinical benefit
Do Not Allow Advertisers to Use My Personal information
